Cancer-associated thromboembolism (CAT) is the second most common cause of mortality in cancer patients (>40%). CAT also complicates the course of malignancy, particularly in the setting of medical and surgical anticancer treatments.

Cancer-associated thromboembolism (CAT) is the second most common cause of mortality in cancer patients (>40%). CAT also complicates the course of malignancy, particularly in the setting of medical and surgical anticancer treatments.

Please sign in to read more